A detailed history of Bank Of America Corp transactions in Bioventus Inc. stock. As of the latest transaction made, Bank Of America Corp holds 168,441 shares of BVS stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
168,441
Previous 42,943 292.24%
Holding current value
$1.94 Million
Previous $246,000 717.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.73 - $11.95 $719,103 - $1.5 Million
125,498 Added 292.24%
168,441 $2.01 Million
Q2 2024

Aug 14, 2024

SELL
$3.96 - $6.93 $22,421 - $39,237
-5,662 Reduced 11.65%
42,943 $246,000
Q1 2024

May 15, 2024

SELL
$4.33 - $5.75 $79,347 - $105,368
-18,325 Reduced 27.38%
48,605 $252,000
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $50,800 - $93,866
17,578 Added 35.62%
66,930 $352,000
Q2 2023

Aug 14, 2023

SELL
$0.93 - $3.64 $12,803 - $50,111
-13,767 Reduced 21.81%
49,352 $142,000
Q1 2023

May 12, 2023

BUY
$1.07 - $2.95 $27,601 - $76,098
25,796 Added 69.12%
63,119 $67,000
Q4 2022

Feb 10, 2023

SELL
$1.81 - $8.14 $1.96 Million - $8.82 Million
-1,084,140 Reduced 96.67%
37,323 $97,000
Q3 2022

Nov 14, 2022

SELL
$6.54 - $9.08 $449,278 - $623,768
-68,697 Reduced 5.77%
1,121,463 $7.85 Million
Q2 2022

Aug 12, 2022

BUY
$6.82 - $13.82 $7.98 Million - $16.2 Million
1,169,541 Added 5672.15%
1,190,160 $8.12 Million
Q1 2022

May 16, 2022

SELL
$11.65 - $15.28 $72,195 - $94,690
-6,197 Reduced 23.11%
20,619 $290,000
Q4 2021

Feb 08, 2022

BUY
$12.37 - $16.77 $321,681 - $436,103
26,005 Added 3206.54%
26,816 $389,000
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $4,890 - $6,158
357 Added 78.63%
811 $12,000
Q2 2021

Sep 13, 2021

BUY
$13.75 - $18.8 $6,242 - $8,535
454 New
454 $8,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $710M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.